Microviable Therapeutics will be presenting at Farmaforum 2023 taking place on September 20th-21th at Madrid. The Microviable team will consist of Claudio Hidalgo, CEO of the company, and Noelia Martínez, R&D Director. Noelia Martínez will [...]
Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]
Microviable Therapeutics Research Scientist Pilar Manrique will be presenting at Microbiome Connect Europe 2023 taking place on July 5th-6th at Amsterdam. Pilar will discuss "A path to develop a donor-based microbiome therapeutic product". Microbiome Connect [...]
Microviable Therapeutics will be presenting at the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. Noelia Martínez, R&D Director, Pilar Manrique, Research Scientist and Marta F. Gosende, Research [...]
Microviable Therapeutics is thrilled to announce that will be attending the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. The event will bring together academic, industry, and investment [...]
Microviable welcomes to the team our new internship student Alejandro Ojeda Suárez, Biologist with a Master's in Physiology and Clinical and Biomedical Laboratory Technician.
We are looking for a full-time, highly motivated lab technician to work on our team on-site (Oviedo, Asturias, Spain). The ideal candidate will have experience in microbiology, biochemistry, immunology, microbiota and probiotics, and will join [...]
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]
Microviable Therapeutics will be presenting at XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. Claudio Hidalgo, CEO at Microviable, Noelia Martínez, R&D Director, and Ignacio [...]
Microviable Therapeutics will be attending the XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. The event will make special mention of the new advances in [...]